Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
The Role of MiRNA Impairment in Wilms' Tumor Formation |
University of Texas Southwestern Medical Center at Dallas / Kenneth Chen, MD |
Young Investigator Grants |
2016 |
Texas |
Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |
V alpha-invariant NKT cells as a novel platform for cancer immunotherapy |
Baylor College of Medicine / Leonid Metelitsa, MD, PhD |
Innovation Grants |
2012 |
Texas |
Parallel sequencing to identify the causes of childhood cancer.
|
Baylor College of Medicine / Sharon Plon, MD, PhD |
Innovation Grants |
2006 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma |
Baylor College of Medicine / Andras Heczey, MD |
Bio-Therapeutic Impact Award |
2017 |
Texas |
Understanding the Role of a Novel Hereditary Cancer Gene |
University of Texas Health Science Center at San Antonio / Patricia Dahia |
Innovation Grants |
2010 |
Texas |
STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML |
Baylor College of Medicine / Michele Redell, M.D./Ph.D. |
Springboard Grants |
2014 |
Texas |
Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide
|
University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD |
Young Investigator Grants |
2008 |
Texas |